Skip to content
DelMar Pharmaceuticals, Inc.
$2,500,000
Registered Direct Offering
Common Stock & Warrants
August 2015
Read More
Trovagene, Inc.
$43,300,000
Public Offering
Common Stock
July 2015
Read More
Tonix Pharmaceuticals Holding Corp.
$20,100,000
Public Offering
Common Stock & Warrants
July 2015
Read More
Wellsense
$2,000,000
Israeli based Company
Private Placement
Preferred Stock and Warrants
June 2015
Read More
Actinium Pharmaceuticals, Inc.
$5,000,000
Registered Direct Offering
Represented Sole Placement Agent
Common Stock
June 2015
Read More
Viking Therapeutics, Inc.
$24,000,000
IPO
Represented Laidlaw & Co. (UK) & Feltl and Co. as Underwriters
Common Stock & Warrants
May 2015
Read More
Vuzix Corporation
$24,800,000
Investment from Intel
January, 2015
Read More
PlasmaTech Biopharmaceuticals, Inc.
$14,000,000
Represented H.C. Wainwright & Co. and Aegis Capital Corp as Underwriters
Common Stock and Warrants
December 2014
Read More
Can-Fite Biopharma Ltd.
$8,000,000
At-the-Market Registered Direct Offering
December 2014
Read More
Contravir Pharmaceuticals, Inc.
$9,000,000
PIPE
Convertible Preferred Stock
November 2014
Read More
